UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

Journal of clinical oncology, 2004-01, Vol.22 (1), p.23-30

2004

Volltextzugriff (PDF)

A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer

Annals of oncology, 2005-10, Vol.16 (10), p.1639-1645

2005

Volltextzugriff (PDF)

Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial

Journal of clinical oncology, 2003-06, Vol.21 (11), p.2059-2069

2003

Volltextzugriff (PDF)

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741

Annals of oncology, 2005-03, Vol.16 (3), p.425-429

2005

Volltextzugriff (PDF)

Randomized Phase II Trial of the Clinical and Biological Effects of Two Dose Levels of Gefitinib in Patients With Recurrent Colorectal Adenocarcinoma

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9265-9274

2005

Volltextzugriff (PDF)

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

Cancer Immunology, Immunotherapy, 2005-03, Vol.54 (3), p.254-264

2005

Volltextzugriff (PDF)

Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282

Annals of oncology, 2001-08, Vol.12 (8), p.1139-1143

2001

Volltextzugriff (PDF)

Liquid chromatographic–mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003-07, Vol.791 (1), p.39-44

2003

Volltextzugriff (PDF)

Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies

Clinical pharmacology and therapeutics, 2009-11, Vol.86 (5), p.519-526

2009

Volltextzugriff (PDF)

Sensitive liquid chromatography–mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003-01, Vol.783 (1), p.231-236

2003

Volltextzugriff (PDF)

Abstract OT3-02-14: A phase 1 study in patients with metastatic breast cancer to evaluate the feasibility of magnetic resonance imaging with ferrumoxytol as a potential biomarker for response to treatment with nanoliposomal irinotecan (nal-IRI, MM-398)

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.OT3-02-14-OT3-02-14

2016

Volltextzugriff (PDF)

Abstract P2-09-02: BMN 673 is a PARP inhibitor in clinical development for the treatment of breast cancer patients with deleterious germline BRCA 1 and 2 mutations

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P2-P2-09-02

2013

Volltextzugriff (PDF)

Dose-Escalating and Pharmacological Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function: A National Cancer Institute Organ Dysfunction Working Group Study

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2664-2672

2003

Volltextzugriff (PDF)

Low Overexpression of HER-2/PPPNeu in Advanced Colorectal Cancer Limits the Usefulness of Trastuzumab (Herceptin registered ) and Irinotecan as Therapy. A Phase II Trial

Cancer investigation, 2004-01, Vol.22 (6), p.858-865

2004

Volltextzugriff (PDF)

Neoadjuvant Imatinib in Gastrointestinal Stromal Tumor of the Rectum: Report of a Case

Diseases of the colon & rectum, 2005-06, Vol.48 (6), p.1316-1319

2005

Volltextzugriff (PDF)

Safety and Toxicity Analysis of Oxaliplatin Combined With Fluorouracil or as a Single Agent in Patients With Previously Treated Advanced Colorectal Cancer

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2904-2911

2003

Volltextzugriff (PDF)

Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients

International journal of nanomedicine, 2012-01, Vol.7 (default), p.5555-5564

2012

Volltextzugriff (PDF)

Phase I Trial, Including Pharmacokinetic and Pharmacodynamic Correlations, of Combination Paclitaxel and Carboplatin in Patients With Metastatic Non–Small-Cell Lung Cancer

Journal of clinical oncology, 1999-02, Vol.17 (2), p.676-684

1999

Volltextzugriff (PDF)

Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the national cancer institute organ dysfunction working group

Seminars in oncology, 2003-08, Vol.30 (4 Suppl 15), p.14-19

2003

Volltextzugriff (PDF)

Treatment of colon and rectal cancer

Journal of clinical gastroenterology, 2002-01, Vol.34 (1), p.15-26

2002

Volltextzugriff (PDF)

Randomized Trial of Influenza Vaccine With Granulocyte-Macrophage Colony-Stimulating Factor or Placebo in Cancer Patients

Journal of clinical oncology, 2002-11, Vol.20 (21), p.4313-4318

2002

Volltextzugriff (PDF)

Chemotherapy for advanced non-small cell lung cancer: past, present, and future

Seminars in oncology, 1997-08, Vol.24 (4), p.440-454

1997

Volltextzugriff (PDF)

Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working group

Seminars in oncology, 2003-08, Vol.30 (4 Suppl 15), p.20-25

2003

Volltextzugriff (PDF)

Relationship between Plasma Exposure of 9-Nitrocamptothecin and Its 9-Aminocamptothecin Metabolite and Antitumor Response in Mice Bearing Human Colon Carcinoma Xenografts

Clinical cancer research, 2005-07, Vol.11 (13), p.4867-4874

2005

Volltextzugriff (PDF)

Pulmonary Infiltrates Following Administration of Paclitaxel

Chest, 1996-07, Vol.110 (1), p.289-292

1996

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(53)
Tagungsberichte
(2)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(45)
Humans
(41)
Biological And Medical Sciences
(30)
Female
(29)
Medical Sciences
(29)
Oncology
(28)
Male
(25)
Middle Aged
(25)
Aged
(22)
Pharmacology. Drug Treatments
(21)
Adult
(18)
Antineoplastic Agents
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(11)
Chemotherapy
(11)
Aged, 80 And Over
(10)
Pharmacology & Pharmacy
(10)
Treatment Outcome
(10)
Antineoplastic Agents - Administration & Dosage
(9)
Camptothecin - Analogs & Derivatives
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer

Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741

Randomized Phase II Trial of the Clinical and Biological Effects of Two Dose Levels of Gefitinib in Patients With Recurrent Colorectal Adenocarcinoma

Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer

Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282

Liquid chromatographic–mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma

Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies

Sensitive liquid chromatography–mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma

Abstract OT3-02-14: A phase 1 study in patients with metastatic breast cancer to evaluate the feasibility of magnetic resonance imaging with ferrumoxytol as a potential biomarker for response to treatment with nanoliposomal irinotecan (nal-IRI, MM-398)

Abstract P2-09-02: BMN 673 is a PARP inhibitor in clinical development for the treatment of breast cancer patients with deleterious germline BRCA 1 and 2 mutations

Dose-Escalating and Pharmacological Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function: A National Cancer Institute Organ Dysfunction Working Group Study

Low Overexpression of HER-2/PPPNeu in Advanced Colorectal Cancer Limits the Usefulness of Trastuzumab (Herceptin registered ) and Irinotecan as Therapy. A Phase II Trial

Neoadjuvant Imatinib in Gastrointestinal Stromal Tumor of the Rectum: Report of a Case

Safety and Toxicity Analysis of Oxaliplatin Combined With Fluorouracil or as a Single Agent in Patients With Previously Treated Advanced Colorectal Cancer

Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients

Phase I Trial, Including Pharmacokinetic and Pharmacodynamic Correlations, of Combination Paclitaxel and Carboplatin in Patients With Metastatic Non–Small-Cell Lung Cancer

Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the national cancer institute organ dysfunction working group

Treatment of colon and rectal cancer

Randomized Trial of Influenza Vaccine With Granulocyte-Macrophage Colony-Stimulating Factor or Placebo in Cancer Patients

Chemotherapy for advanced non-small cell lung cancer: past, present, and future

Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working group

Relationship between Plasma Exposure of 9-Nitrocamptothecin and Its 9-Aminocamptothecin Metabolite and Antitumor Response in Mice Bearing Human Colon Carcinoma Xenografts

Pulmonary Infiltrates Following Administration of Paclitaxel

Suchergebnisse filtern